RxDoctor Payments Data

Taelor Young

Physician Assistant · Oak Park, CANPI 1073150744

Payments from drug & device makers

$8,594in general payments, 2019–2025

Across 535 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • Lilly USA, LLC$1K
  • Novo Nordisk$937
  • Biohaven Pharmaceutical Holding Company Ltd.$448
  • Pfizer$401
  • plus $2K from 26 others

What the payments were for

  • Travel & lodging$2363%
  • Food & beverage$8,32597%
  • Education$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,594 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide56$60,000
OzempicSemaglutide11$17,018
FarxigaDapagliflozin Propanediol12$13,810
BelsomraSuvorexant11$4,915
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$1,998
SynthroidLevothyroxine Sodium12$1,164
Oxycodone Hcl16$904
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$799
Levothyroxine Sodium63$782
Pregabalin17$713
Gabapentin41$677
Albuterol Sulfate HfaAlbuterol Sulfate42$650
Atorvastatin Calcium83$526
Estradiol13$464
Celecoxib12$408

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$1,079$60,00056 claims
Novo NordiskOzempic$937$17,01811 claims
AstraZenecaFarxiga$257$13,81012 claims
MerckBelsomra$18$4,91511 claims
AbbVieSynthroid$2,070$1,16412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Oak Park

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →